Indegene Ltd
NSE: INDGN BSE: 544172
₹571.90
-16.20 (2.75%)
Tue, 27 Oct 2026, 05:24 am
Market Cap (in Cr)13771.25
PE Ratio34.45
Dividend0.39
Health Technology
Pharmaceuticals: Major
24.5KIndegene Ltd Company History
1998
- Incorporated as Indegene Lifesystems Private Limited.
2003
- Shifted the registered office from Gujarat to Karnataka.
2005
- Raised funding from Nadathur Holdings & Investments Private Limited.
- Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.
- Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore.
2006
- Acquired Medsn, Inc., a company engaged in medical education and marketing business.
2007
- Expanded services to include European territory.
2008
- Received BS ISO/IEC 27001:2005 certification for information security management system.
2009
- Received ISO 9001:2000 certification for quality management system.
2012
- Expanded operations to China by incorporating Indegene Lifesystems Consulting (Shanghai) Co., Ltd.
2014
- Shifted the registered office from Karnataka to Maharashtra.
2016
- Changed the company name to Indegene Private Limited.
- Shifted the registered office from Karnataka to Maharashtra.
2017
- Acquired the Encima Group, Inc., a corporation operating a digital service, marketing automation and analytics services business.
- Shifted the registered office from Maharashtra to Karnataka.
2020
- Acquired DT Associates Research and Consulting Services Limited, a consulting services company in UK.
- Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences.
2021
- Expanded operations to Japan by incorporating Indegene Japan, LLC.
- Raised equity funding from CA Dawn Investments and Brighton Park Capital.
- Received BS ISO/IEC 27701:2019 certification for privacy information management system.
2022
- Acquired Medical Marketing Economics, LLC, and subsequently merged it with Indegene, Inc.
- Expanded global operations with new offices in Mexico.
- Converted from a private limited company to a public limited company.
- Changed the company name to Indegene Limited.
2023
- Acquired Cult Health, a company providing advertising services to parties in the healthcare sector.
- Acquired Indegene Healthcare Germany GmbH, expanding presence in Europe.
- Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform.
2024
- Acquired Trilogy Writing & Consulting GmbH, a company providing high-end medical writing to customers.
- Acquired three wholly owned subsidiaries of Trilogy Writing & Consulting GmbH.
- Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India.
